fda_recall · drug_recall · high
Cipla USA, Inc. — Class II recall: Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 sa…
- Event date
- 2026-04-15 00:00:00Z
- Observed
- 2026-07-09 22:51:51Z
- Source ID
- D-0422-2026
- Payload hash
- 1992e146d3f23f6c2cf61ca6…
Summary
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. Status: Ongoing.
Entities
Informational only. Not legal, financial, or medical advice.